Shandong Realcan Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2024: -4.18%

Shandong Realcan Pharmaceutical Co Ltd (002589) has an Asset Resilience Ratio of -4.18% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Shandong Realcan Pharmaceutical Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥-650.47 Million
≈ $-95.18 Million USD Cash + Short-term Investments

Total Assets

CN¥15.56 Billion
≈ $2.28 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2023)

This chart shows how Shandong Realcan Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See 002589 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Shandong Realcan Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Shandong Realcan Pharmaceutical Co Ltd worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥-650.47 Million -4.18%
Total Liquid Assets CN¥-650.47 Million -4.18%

Asset Resilience Insights

  • Limited Liquidity: Shandong Realcan Pharmaceutical Co Ltd maintains only -4.18% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Shandong Realcan Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shandong Realcan Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Sigma Healthcare Ltd
AU:SIG
Medical Distribution 0.03%
Cyclopharm Ltd
AU:CYC
Medical Distribution 1.98%
Ebos Group Ltd
AU:EBO
Medical Distribution 0.00%
Paragon Care Ltd
AU:PGC
Medical Distribution 0.00%
Mayne Pharma Group Ltd
AU:MYX
Medical Distribution 4.00%
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Medical Distribution 4.48%
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
Medical Distribution 4.44%
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
Medical Distribution 5.56%

Annual Asset Resilience Ratio for Shandong Realcan Pharmaceutical Co Ltd (2015–2023)

The table below shows the annual Asset Resilience Ratio data for Shandong Realcan Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 -3.99% CN¥-666.13 Million
≈ $-97.48 Million
CN¥16.71 Billion
≈ $2.45 Billion
+1.98pp
2022-12-31 -5.97% CN¥-1.09 Billion
≈ $-160.10 Million
CN¥18.33 Billion
≈ $2.68 Billion
-3.05pp
2021-12-31 -2.92% CN¥-770.06 Million
≈ $-112.68 Million
CN¥26.40 Billion
≈ $3.86 Billion
-3.05pp
2020-12-31 0.13% CN¥40.79 Million
≈ $5.97 Million
CN¥31.29 Billion
≈ $4.58 Billion
-0.48pp
2019-12-31 0.61% CN¥198.09 Million
≈ $28.99 Million
CN¥32.47 Billion
≈ $4.75 Billion
+0.39pp
2018-12-31 0.22% CN¥77.83 Million
≈ $11.39 Million
CN¥34.84 Billion
≈ $5.10 Billion
+0.21pp
2017-12-31 0.01% CN¥2.54 Million
≈ $371.80K
CN¥26.98 Billion
≈ $3.95 Billion
+0.08pp
2016-12-31 -0.07% CN¥-11.55 Million
≈ $-1.69 Million
CN¥15.66 Billion
≈ $2.29 Billion
+0.00pp
2015-12-31 -0.08% CN¥-6.91 Million
≈ $-1.01 Million
CN¥8.86 Billion
≈ $1.30 Billion
--
pp = percentage points

About Shandong Realcan Pharmaceutical Co Ltd

SHE:002589 China Medical Distribution
Market Cap
$700.19 Million
CN¥4.78 Billion CNY
Market Cap Rank
#10852 Global
#3199 in China
Share Price
CN¥3.18
Change (1 day)
-2.15%
52-Week Range
CN¥2.81 - CN¥4.69
All Time High
CN¥17.35
About

Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institutions in China. It operates through the Drug and Equipment Distribution, In Vitro Diagnostics, Pharmaceutical Logistics, Traditional Chinese Medicine, and Microbiome Medicine segments. The company engages in the processing, manufacture, sale, and wholesale of Chinese medicinal materi… Read more